In a world undergoing rapid technological transformation, healthcare stands as a field profoundly impacted by innovations such as artificial intelligence (AI), genetic engineering, and biotechnology. The integration of AI in healthcare offers transformative potential, yet it comes with a unique set of challenges and ethical considerations. Recent biotechnological breakthroughs spanning fields such as genetic engineering, generative AI, and drug delivery have enabled unprecedented opportunities for the development of novel therapeutics.

In this event, we want to discuss the promises and the future of medicine and biotechnology. What key technologies will shape the industry’s trajectory? What are the challenges associated with bringing these revolutionary treatments to patients? What role do academia, biopharmaceutical companies, and startups play in the innovations in this field? What are the implications for our healthcare systems? All of this will be discussed in the context of transatlantic partnership: what can we learn from each other and how can we work together on both sides of the Atlantic to spark innovation in biotechnology and pharma?

With Nikolai Slavov, Aaron Morris, Thorsten Wirkes, and Martina Kerscher, moderated by Lukas Lange